Table 7 Effectiveness (avoided strokes): Deterministic Sensitivity Analysis (by country)
Strokes prevented | Range | Switzerland | Germany | Greece | Netherlands | Poland | Serbia | UK |
|---|---|---|---|---|---|---|---|---|
(per 1000 screening participants) | ||||||||
Base Case | Â | 2.53 | 3.65 | 3.06 | 2.48 | 4.43 | 3.43 | 3.06 |
Ratio Unkown vs. known AF | [10% ... 75%] | [0.8–5.7] | [1.1–8.2] | [0.9–6.9] | [0.7–5.6] | [1.3–10.0] | [1.0–7.7] | [0.9–6.9] |
Stroke incidence (OAC vs. No OAC) | [−20%;+ 20%] | [1.9–3.2] | [2.7–4.7] | [2.3–4.0] | [1.9–3.1] | [3.3–5.8] | [2.5–4.6] | [2.3–3.9] |
AF prevalence | [−20%;+ 20%] | [2.0–3.0] | [2.9–4.4] | [2.4–3.7] | [2.0–3.0] | [3.5–5.3] | [2.7–4.1] | [2.4–3.7] |
Stroke incidence | [−20%;+ 20%] | [2.2–2.8] | [3.2–4.0] | [2.7–3.3] | [2.1–2.8] | [4.0–4.7] | [3.2–3.6] | [2.7–3.4] |
Stroke incidence (AF vs. No AF) | [−20%;+ 20%] | [2.2–2.8] | [3.2–4.0] | [2.7–3.3] | [2.1–2.8] | [4.0–4.7] | [3.2–3.6] | [2.7–3.4] |